Immune checkpoint inhibitors in mCRPC-rationales, challenges and perspectives

Taghizadeh, H; Marhold, M; Tomasich, E; Udovica, S; Merchant, A; Krainer, M

Krainer, M (reprint author), Med Univ Vienna, Clin Div Oncol, Dept Med 1, Vienna, Austria.

ONCOIMMUNOLOGY, 2019; 8 (11):

Abstract

The advancement of immune-therapeutics in cancer treatment has proven to be promising in various malignant diseases. However, in castration resistant ......

Full Text Link